Previous close | 35.56 |
Open | 35.33 |
Bid | 35.20 x 600 |
Ask | 35.28 x 300 |
Day's range | 34.77 - 35.82 |
52-week range | 13.82 - 40.74 |
Volume | |
Avg. volume | 1,734,519 |
Market cap | 2.275B |
Beta (5Y monthly) | 1.13 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.43 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 36.93 |
Tandem Diabetes Care (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN DIEGO, April 09, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results.
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...